WHO ICTRP trial
Improving Neuroprotective Strategy for Ischemic Stroke before Endovascular…
ChiCTR2500113387 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113387 |
|---|---|
| Public title | Improving Neuroprotective Strategy for Ischemic Stroke before Endovascular Thrombectomy by Intravenous Tirofiban |
| Scientific title | Improving Neuroprotective Strategy for Ischemic Stroke before Endovascular Thrombectomy by Intravenous Tirofiban |
| Primary sponsor | General Hospital of Northern Theater Command |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Ischemic stroke |
| Interventions | Tirofiban group:Patients will receive intravenous tirofiban before endovascular treatment(0.4 µg/kg/min, intravenous infusion within 30 minutes, and 0.1 µg/kg/min intravenous infusion for 23.5 hours). ;Placebo group:Patients will receive… |
| Registration date | Nov 27, 2025 |
| Target size | Tirofiban group:442;Placebo group:442 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: